MORGAN STANLEY - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 72 filers reported holding HUMACYTE INC in Q3 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$229,433
-13.4%
78,305
-15.5%
0.00%
Q2 2023$265,037
+13.4%
92,670
+22.5%
0.00%
Q1 2023$233,743
+125.8%
75,645
+54.2%
0.00%
Q4 2022$103,514
-32.3%
49,059
+4.5%
0.00%
Q3 2022$153,000
+18.6%
46,968
+17.0%
0.00%
Q2 2022$129,000
-57.0%
40,143
-5.8%
0.00%
Q1 2022$300,000
-55.0%
42,603
-53.6%
0.00%
Q4 2021$666,000
-20.7%
91,817
+26.9%
0.00%
Q3 2021$840,00072,3430.00%
Other shareholders
HUMACYTE INC shareholders Q3 2022
NameSharesValueWeighting ↓
York Capital Management Global Advisors, LLC 2,291,397$16,613,0003.70%
Monashee Investment Management LLC 399,910$2,899,0000.72%
Endowment Wealth Management, Inc. 96,618$700,0000.71%
Gladstone Institutional Advisory LLC 246,717$1,7890.14%
Diameter Capital Partners LP 300,338$2,177,0000.13%
CenterBook Partners LP 23,706$172,0000.10%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 900,100$6,526,000,0000.06%
Exos Asset Management LLC 16,139$117,0000.06%
Maven Securities LTD 200,000$1,450,0000.04%
VALLEY FORGE INVESTMENT CONSULTANTS INC ADV 11,000$80,0000.04%
View complete list of HUMACYTE INC shareholders